Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID‐19

Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice

Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,730 · see citing works

Acute Respiratory Distress Syndrome

Ards Definition Task Force (2012) · JAMA · doi:10.1001/jama.2012.5669 · Cited by 8,806 · see citing works

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,967 · see citing works

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 4,950 · see citing works

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775 · see citing works

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., Fan, Y., & Zheng, C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30086-4 · Cited by 3,664 · see citing works

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097 · see citing works

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L. Y., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,665 · see citing works

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592 · see citing works

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542 · see citing works

Targeting Autophagy in Cancer

Levy, J. M. M., Towers, C. G., & Thorburn, A. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.53 · Cited by 2,526 · see citing works

Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion

Mauthe, M., Orhon, I., Rocchi, C., Zhou, X., Luhr, M., Hijlkema, K.-J., Coppes, R. P., Engedal, N., Mari, M., & Reggiori, F. (2018) · Autophagy · doi:10.1080/15548627.2018.1474314 · Cited by 2,122 · see citing works

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hú, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,070 · see citing works

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2

Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882 · see citing works

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,813 · see citing works

Immunology of COVID-19: Current State of the Science

Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623 · see citing works

Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance

Fidock, D. A., Nomura, T., Talley, A. K., Cooper, R. A., Dzekunov, S. M., Ferdig, M. T., Ursos, L. M. B., Sidhu, A. B. S., Naudé, B., Deitsch, K., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00077-8 · Cited by 1,460 · see citing works

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

Boulware, D. R., Pullen, M. F., Bangdiwala, A. S., Pastick, K. A., Lofgren, S. M., Okafor, E. C., Skipper, C. P., Nascene, A. A., Nicol, M. R., Abassi, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2016638 · Cited by 1,320 · see citing works

Effects of chloroquine on viral infections: an old drug against today's diseases

Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,272 · see citing works

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J. M., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.8630 · Cited by 1,162 · see citing works

A human monoclonal antibody blocking SARS-CoV-2 infection

Wang, C., Li, W., Drabek, D., Okba, N. M. A., van Haperen, R., Osterhaus, A. D. M. E., van Kuppeveld, F. J. M., Haagmans, B. L., Grosveld, F. G., & Bosch, B. (2020) · Nature Communications · doi:10.1038/s41467-020-16256-y · Cited by 1,115 · see citing works

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Devaux, C. A., Rolain, J., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,099 · see citing works

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

Borba, M. G. S., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., Brito, M., Mourão, M. P. G., Brito-Sousa, J. D., Baía-da-Silva, D., Guerra, M. V. F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8857 · Cited by 1,038 · cited 4× · see citing works

Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19

Liu, Y., Du, X., Chen, J., Jin, Y., Peng, L. H., Wang, H., Luo, M., Chen, L., & Zhao, Y. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.002 · Cited by 1,033 · see citing works

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria

Achan, J., Talisuna, A. O., Erhart, A., Yeka, A., Tibenderana, J., Baliraine, F. N., Rosenthal, P. J., & D’Alessandro, U. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-144 · Cited by 1,010 · see citing works

A Molecular Marker for Chloroquine-Resistant Falciparum Malaria

DJIMDÉ, A. A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourte, Y., Coulibaly, D. M., Dicko, A., Su, X., Nomura, T., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440403 · Cited by 1,010 · see citing works

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105932 · Cited by 937 · see citing works

Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture

Velthuis, A. J. W. T., van den Worm, S. H. E., Sims, A. M., Baric, R. S., Snijder, E. J., & van Hemert, M. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001176 · Cited by 895 · see citing works

Chloroquine‐Resistant Malaria

Wellems, T. E., & Plowe, C. V. (2001) · The Journal of Infectious Diseases · doi:10.1086/322858 · Cited by 834 · see citing works

Neutrophil to lymphocyte ratio and cardiovascular diseases: a review

Bhat, T., Teli, S., Rijal, J. P., Bhat, H., Raza, M. R., Khoueiry, G., Meghani, M., Akhtar, M. S., & Costantino, T. G. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.159 · Cited by 767 · see citing works

Angiotensin II revisited: new roles in inflammation, immunology and aging

Benigni, A., Cassis, P., & Remuzzi, G. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000080 · Cited by 757 · see citing works

Quinolines and structurally related heterocycles as antimalarials

Kaur, K., Jain, M., Reddy, R. P., & Jain, R. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.04.011 · Cited by 733 · see citing works

Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03036-14 · Cited by 653 · see citing works

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644 · see citing works

Hydroxychloroquine: From Malaria to Autoimmunity

Ben‐Zvi, I., Kivity, S., Langevitz, P., & Shoenfeld, Y. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8243-x · Cited by 616 · see citing works

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2

Chan, K. K., Dorosky, D. E., Sharma, P. A., Abbasi, S. A., Dye, J. M., Kranz, D. M., Herbert, A. S., & Procko, E. (2020) · Science · doi:10.1126/science.abc0870 · Cited by 613 · see citing works

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

Khan, A., Benthin, C., Zeno, B. R., Albertson, T. E., Boyd, J. H., Christie, J. D., Hall, R., Poirier, G., Ronco, J. J., Tidswell, M., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1823-x · Cited by 600 · see citing works

New insights into the antiviral effects of chloroquine

Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570 · see citing works

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

Mahévas, M., Tran, V.-T., Roumier, M., Chabrol, A., Paule, R., Guillaud, C., Foïs, E., Lepeule, R., Szwebel, T., Lescure, F.-X., et al. (2020) · BMJ · doi:10.1136/bmj.m1844 · Cited by 566 · see citing works

ACE2 , angiotensin‐(1‐7) and M as receptor axis in inflammation and fibrosis

Silva, A. C. S. E., da Silveira, K. D., Ferreira, A., & Teixeira, M. M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12159 · Cited by 546 · see citing works

Of chloroquine and COVID-19

Touret, F., & de Lamballerie, X. N. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104762 · Cited by 544 · see citing works

The intracellular trafficking pathway of transferrin

Mayle, K. M., Le, A. M., & Kamei, D. T. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.09.009 · Cited by 453 · see citing works

CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement

Ulrich, H., & Pillat, M. M. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09976-7 · Cited by 418 · see citing works

Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19

Yang, N., & Shen, H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45498 · Cited by 408 · see citing works

Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases

Al‐Bari, M. A. A. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.293 · Cited by 387 · see citing works

The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites

Delves, M. J., Plouffe, D., Scheurer, C., Meister, S., Wittlin, S., Winzeler, E. A., Sinden, R. E., & Leroy, D. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001169 · Cited by 378 · see citing works

Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS

He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 365 · see citing works

Bi-directional differentiation of single bronchioalveolar stem cells during lung repair

Liu, K., Tang, M., Liu, Q., Han, X., Jin, H., Zhu, H., Li, Y., He, L., Ji, H., & Zhou, B. (2020) · Cell Discovery · doi:10.1038/s41421-019-0132-8 · Cited by 360 · see citing works

COVID-19: risk for cytokine targeting in chronic inflammatory diseases?

Schett, G. A., Sticherling, M., & Neurath, M. F. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0312-7 · Cited by 349 · see citing works

Chloroquine Transport via the Malaria Parasite’s Chloroquine Resistance Transporter

Martin, R. E., Marchetti, R. V., Cowan, A. I., Howitt, S. M., Bröer, S., & Kirk, K. (2009) · Science · doi:10.1126/science.1175667 · Cited by 334 · see citing works

Insights from nanomedicine into chloroquine efficacy against COVID-19

Hu, Y., Frieman, M. B., & Wolfram, J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0674-9 · Cited by 321 · see citing works

Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate

McChesney, E. W. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91265-2 · Cited by 316 · see citing works

Contribution of the pfmdr1 gene to antimalarial drug-resistance

Duraisingh, M. T., & Cowman, A. F. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.008 · Cited by 300 · see citing works

Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease

Jia, H. (2016) · Shock · doi:10.1097/shk.0000000000000633 · Cited by 296 · see citing works

Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic

South, A. M., Tomlinson, L. A., Edmonston, D. L., Hiremath, S. S., & Sparks, M. A. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0279-4 · Cited by 281 · see citing works

Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs

Fitch, C. D. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.003 · Cited by 241 · see citing works

A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension

Hemnes, A. R., Rathinasabapathy, A., Austin, E. A., Brittain, E. L., Carrier, E. J., Chen, X., Fessel, J. P., Fike, C. D., Fong, P., Fortune, N. L., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02638-2017 · Cited by 221 · see citing works

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19

Hernández, A. V., Roman, Y. M., Pasupuleti, V., Barboza, J. J., & White, C. M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2496 · Cited by 221 · see citing works

Quinoline Drug–Heme Interactions and Implications for Antimalarial Cytostatic versus Cytocidal Activities

Gorka, A. P., de Dios, A., & Roepe, P. D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400282d · Cited by 191 · see citing works

Antimalarial drugs inhibiting hemozoin (β-hematin) formation: A mechanistic update

Kumar, S., Guha, M., Choubey, V., Maity, P., & Bandyopadhyay, U. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.11.008 · Cited by 180 · see citing works

The Use of Antimalarial Drugs against Viral Infection

D’Alessandro, S., Scaccabarozzi, D., Signorini, L., Perego, F., Ilboudo, D. P., Ferrante, P., & Delbue, S. (2020) · Microorganisms · doi:10.3390/microorganisms8010085 · Cited by 174 · see citing works

Evaluating Nanoparticle Sensor Design for Intracellular pH Measurements

Benjaminsen, R. V., Sun, H., Henriksen, J. R., Christensen, N. M., Almdal, K., & Andresen, T. L. (2011) · ACS Nano · doi:10.1021/nn201643f · Cited by 168 · see citing works

What’s new in the renin-angiotensin system?

Warner, F. J., Smith, A. I., Hooper, N. M., & Turner, A. J. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4240-7 · Cited by 153 · see citing works

Antimalarial Drugs: Modes Of Action And Mechanisms Of Parasite Resistance

Müller, I. B., & Hyde, J. E. (2010) · Future Microbiology · doi:10.2217/fmb.10.136 · Cited by 149 · see citing works

Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodelling

McKinney, C. A., Fattah, C., Loughrey, C. M., Milligan, G., & Nicklin, S. A. (2014) · Clinical Science · doi:10.1042/cs20130436 · Cited by 142 · see citing works

Corticosteroids Block Autophagy Protein Recruitment in <i>Aspergillus fumigatus</i> Phagosomes via Targeting Dectin-1/Syk Kinase Signaling

Kyrmizi, I., Gresnigt, M. S., Akoumianaki, T., Samonis, G., Sidiropoulos, P., Boumpas, D., Netea, M. G., van de Veerdonk, F. L., Kontoyiannis, D. P., & Chamilos, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300132 · Cited by 142 · see citing works

Kinetic Mechanism of Quinone Oxidoreductase 2 and Its Inhibition by the Antimalarial Quinolines

Kwiek, J. J., Haystead, T., & Rudolph, J. (2004) · Biochemistry · doi:10.1021/bi035923w · Cited by 134 · see citing works

Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2

Wang, S., Guo, F., Liu, K., Wang, H., Rao, S., Yang, P., & Jiang, C. (2008) · Virus Research · doi:10.1016/j.virusres.2008.03.004 · Cited by 134 · see citing works

Palmitoylation of the cysteine-rich endodomain of the SARS–coronavirus spike glycoprotein is important for spike-mediated cell fusion

Petit, C. M., Chouljenko, V. N., Iyer, A. V., Colgrove, R., Farzan, M., Knipe, D. M., & Kousoulas, K. G. (2006) · Virology · doi:10.1016/j.virol.2006.10.034 · Cited by 132 · see citing works

High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients

Wang, W., Su, B., Pang, L., Qiao, L., Feng, Y., Ouyang, Y., Guo, X., Shi, H., Wei, F., Su, X., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0447-2 · Cited by 132 · see citing works

From Mitochondria to Disease: Role of the Renin-Angiotensin System

de Cavanagh, E. M. V., Inserra, F., Ferder, M., & Ferder, L. (2007) · American Journal of Nephrology · doi:10.1159/000107757 · Cited by 124 · see citing works

Hemozoin Biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors

Hempelmann, E. (2006) · Parasitology Research · doi:10.1007/s00436-006-0313-x · Cited by 124 · see citing works

Dengue Fever, COVID ‐19 ( SARS‐CoV ‐2), and Antibody‐Dependent Enhancement ( ADE ): A Perspective

Ulrich, H., Pillat, M. M., & Tárnok, A. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24047 · Cited by 122 · see citing works

Diagnosis of Chloroquine Cardiomyopathy by Endomyocardial Biopsy

Ratliff, N. B., Estes, M. L., Myles, J. L., Shirey, E. K., & McMahon, J. T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701223160405 · Cited by 121 · see citing works

Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate

Lisewski, A. M., Quiros, J. P., Ng, C. L., Adikesavan, A. K., Miura, K., Putluri, N., Eastman, R. T., Scanfeld, D., Regenbogen, S., Altenhofen, L., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.011 · Cited by 117 · see citing works

Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal

Fantini, J., Chahinian, H., & Yahi, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106020 · Cited by 117 · see citing works

SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via the cyclin D3/pRb pathway

Yuan, X., Wu, J., Shan, Y., Yao, Z., Dong, B., Chen, B., Zhao, Z., Wang, S., Chen, J., & Cong, Y. (2005) · Virology · doi:10.1016/j.virol.2005.10.015 · Cited by 113 · see citing works

pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective

Cooper, R. A., Hartwig, C. L., & Ferdig, M. T. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.04.004 · Cited by 107 · see citing works

SARS‐CoV‐2, the Virus that Causes COVID‐19: Cytometry and the New Challenge for Global Health

Cossarizza, A., Biasi, S. D., Guaraldi, G., Girardis, M., & Mussini, C. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24002 · Cited by 103 · see citing works

The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2Preprint

Procko, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.16.994236 · Cited by 99 · see citing works

Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype

Martens, G. A., Jiang, L., Hellemans, K., Stangé, G. M., Heimberg, H., Nielsen, F. C., Sand, O., van Helden, J., Gorus, F., & PIPELEERS, D. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024134 · Cited by 93 · see citing works

Genome-Wide Compensatory Changes Accompany Drug- Selected Mutations in the Plasmodium falciparum crt Gene

Jiang, H., Patel, J. J., Yi, M., Mu, J., Ding, J., Stephens, R. M., Cooper, R. A., Ferdig, M. T., & Su, X. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002484 · Cited by 81 · see citing works

Angiotensin II and Nitric Oxide Interaction

Marc De Gasparo, B. (2002) · Heart Failure Reviews · doi:10.1023/a:1020714518246 · Cited by 79 · see citing works

HIV Protease Inhibitors Disrupt Lipid Metabolism by Activating Endoplasmic Reticulum Stress and Inhibiting Autophagy Activity in Adipocytes

Zha, B. S., Wan, X., Zhang, X., Zha, W., Zhou, J. L., Wabitsch, M., Wang, G., Lyall, V., Hylemon, P. B., & Zhou, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059514 · Cited by 79 · see citing works

Plasmodium falciparumNa+/H+Exchanger 1 Transporter Is Involved in Reduced Susceptibility to Quinine

Henry, M., Briolant, S., Zettor, A., Pelleau, S., Baragatti, M. C., Baret, E., Mosnier, J., Amalvict, R., Fusaı̈, T., Rogier, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01243-08 · Cited by 72 · see citing works

Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19Preprint

Yu, B., Li, C., Chen, P., Zhou, N., Wang, L., Li, J., Jiang, H., & Wang, D. W. (2020) · medRxiv · doi:10.1101/2020.04.27.20073379 · Cited by 68 · see citing works

Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties

Smit, C., Peeters, M. Y. M., van den Anker, J. N., & Knibbe, C. A. J. (2020) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00891-1 · Cited by 63 · see citing works

A glimpse into the eye of the COVID-19 cytokine storm

Kuppalli, K., & Rasmussen, A. L. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102789 · Cited by 61 · see citing works

Role of DifferentPfcrt andPfmdr-1 Mutations in Conferring Resistance to Antimalaria Drugs inPlasmodium falciparum

Ibraheem, Z. O., Majid, R. A., Noor, S. M., Sedik, H., & Basir, R. (2014) · Malaria Research and Treatment · doi:10.1155/2014/950424 · Cited by 60 · see citing works

The depressor axis of the renin–angiotensin system and brain disorders: a translational approach

Gironacci, M. M., Vicario, A., Cerezo, G., & Silva, M. G. (2018) · Clinical Science · doi:10.1042/cs20180189 · Cited by 60 · see citing works

Regulation of endocytic trafficking and acidification are independent of the cystic fibrosis transmembrane regulator.

Dunn, K. W., Park, J., Semrad, C. E., Gelman, D. L., Shevell, T., & McGraw, T. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37692-5 · Cited by 55 · see citing works

Levels of Chloroquine Resistance inPlasmodium falciparumAre Determined by Loci Other thanpfcrtandpfmdr1

Chen, N., Russell, B., Fowler, E. V., Peters, J. M., & Cheng, Q. (2002) · The Journal of Infectious Diseases · doi:10.1086/338470 · Cited by 49 · see citing works

Angiotensin (1−7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice

Li, Y. H., Wu, J., He, Q., Shou, Z., Zhang, P., Pen, W., Zhu, Y., & Chen, J. (2009) · Hypertension Research · doi:10.1038/hr.2009.25 · Cited by 45 · see citing works

Antiretroviral-Mediated Microglial Activation Involves Dysregulated Autophagy and Lysosomal Dysfunction

Tripathi, A., Thangaraj, A., Chivero, E. T., Periyasamy, P., Callen, S. E., Burkovetskaya, M. E., Guo, M., & Buch, S. J. (2019) · Cells · doi:10.3390/cells8101168 · Cited by 40 · see citing works

Chemical Proteomics and Super-resolution Imaging Reveal That Chloroquine Interacts with Plasmodium falciparum Multidrug Resistance-Associated Protein and Lipids

Woodland, J. G., Hunter, R., Smith, P. J., & Egan, T. J. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00583 · Cited by 36 · see citing works

T regulatory cells activation and distribution are modified in critically ill patients with acute respiratory distress syndrome: A prospective single-centre observational study

Halter, S., Aimade, L., Barbié, M., Brisson, H., Rouby, J., Langeron, O., Klatzmann, D., Rosenzwajg, M., & Monsel, A. (2019) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2019.07.014 · Cited by 32 · see citing works

Clinical Pharmacokinetics 1990

Matzke, G. R., & Peter, W. L. S. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018010-00001 · Cited by 27 · see citing works

Big studies dim hopes for hydroxychloroquine

Kupferschmidt, K. (2020) · Science · doi:10.1126/science.368.6496.1166 · Cited by 24 · see citing works

Three big studies dim hopes that hydroxychloroquine can treat or prevent COVID-19

(2020) · AAAS Articles DO Group · doi:10.1126/science.abd2496 · Cited by 21 · see citing works

Interferon-alpha-2b induces autophagy in hepatocellular carcinoma cells through Beclin1 pathway.

Zhao, J., Wang, M., Zeng, L., Gao, D.-M., Cai, Y., Chang, J., & Wang, S. (2014) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2014.01.006 · Cited by 17 · see citing works

Ruxolitinib Regulates the Autophagy Machinery in Multiple Myeloma Cells

Kuşoğlu, A., Bağca, B. G., Ay, N. P. O., Saydam, G., & Avcı, Ç. B. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200218105159 · Cited by 17 · see citing works

New insights into the elucidation of angiotensin‐(1–7) in vivo antiarrhythmic effects and its related cellular mechanisms

Joviano‐Santos, J. V., Santos‐Miranda, A., Joca, H. C., Cruz, J. S., & Ferreira, A. J. (2016) · Experimental Physiology · doi:10.1113/ep085884 · Cited by 16 · see citing works

A convenient cell fusion assay for the study of SARS‐CoV entry and inhibition

Sha, Y., Wu, Y.-L., Cao, Z.-J., Xu, X.-L., Wu, W., Jiang, D., Mao, X., Liu, H., Zhu, Y., Gong, R., et al. (2006) · IUBMB Life · doi:10.1080/15216540600820974 · Cited by 13 · see citing works

Potential role of Plasmodium falciparum exported protein 1 in the chloroquine mode of action

Lisewski, A. M., Quiros, J. P., Mittal, M., Putluri, N., Sreekumar, A., Haeggström, J. Z., & Lichtarge, O. (2017) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2017.12.003 · Cited by 11 · see citing works

Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology

Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works

Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems

Guimarães, L. M. F., Rossini, C. V. T., & Lameu, C. (2021) · Nitric Oxide · doi:10.1016/j.niox.2021.04.003 · Cited by 61 · see citing works

G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19)

Yang, H., Ma, T., Tjong, W.-Y., Stern, A., & Chiu, D. T.-Y. (2021) · Free Radical Research · doi:10.1080/10715762.2020.1866757 · Cited by 47 · see citing works

Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational

Mansouri, K., Rastegari‐Pouyani, M., Ghanbari-Movahed, M., Safarzadeh, M., Kiani, S., & Ghanbari‐Movahed, Z. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110694 · Cited by 24 · see citing works

Malaria Epidemiology and COVID-19 Pandemic: Are They Interrelated?

Prabhu, S. R., Ware, A. P., Saadi, A. V., Brand, A. M., Ghosh, S. K., Kamath, A., & Satyamoorthy, K. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0227 · Cited by 14 · see citing works

Virus adaptation to heparan sulfate comes with capsid stability tradeoff

Tee, H. K., Crouzet, S., Muliyil, A., Mathez, G., Cagno, V., Peraro, M. D., Antanasijevic, A., Clément, S., & Tapparel, C. (2024) · eLife · doi:10.7554/elife.98441 · Cited by 10 · see citing works

Understanding the interplay of malarial pathogenesis, host immune response and oxidative stress: Implications for disease progression and therapeutic strategies

Buthelezi, M. N., Masia, K. J., Masamba, P., Simelane, M. B. C., & Kappo, A. P. (2025) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2025.100082 · Cited by 10 · see citing works

Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes

Kim, Y. S., Lee, S. Y., Yoon, J. W., Kim, D., Yu, S., Kim, J., & Kim, J. H. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.10.165 · Cited by 7 · see citing works

Antimalarial analysis of pharmaceutical formulations and biological samples by capillary electrophoresis: the state of the art and applications

de Souza, J. C. Q., Penna, E. A., Chellini, P. R., & de Oliveira, M. A. L. (2024) · Analytical Methods · doi:10.1039/d4ay00860j · Cited by 5 · see citing works

In silico analysis of Coenzyme Q10 interaction with the heme-hemoglobin complex: Implications for oxidative stress and inflammation in severe malaria

Ouko, D. B., Musila, F. M., Amwayi, P. W., Mwaeni, V. K., Kinyanyi, D. B., Gitau, G. W., Isaac, A. O., & Nyariki, J. N. (2026) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2026.01.001 · Cited by 2 · see citing works

In vivo antimalarial effect of 1-hydroxy-5,6,7-trimethoxyxanthone isolated from Mammea siamensis T. Anders. flowers: pharmacokinetic and acute toxicity studies

Chaniad, P., Chukaew, A., Na-Ek, P., Yusakul, G., Chuaboon, L., Phuwajaroanpong, A., Plirat, W., Konyanee, A., Septama, A. W., & Punsawad, C. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04427-z · Cited by 3 · see citing works

The potential of drug delivery nanosystems to treat COVID-19

García-Silva, I., Palestino, G., & González‐Ortega, O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90248-9.00018-8 · Cited by 1 · see citing works

Antimalarial drug prophylaxis and paediatric COVID-19 in malaria endemic area

Keebayoon, A., & Wiwanitkit, V. (2021) · Sri Lanka Journal of Child Health · doi:10.4038/sljch.v50i2.9594

COVID-19, Hydroxychloroquine, Comorbidity, Systemic Lupus Erythematosus, and Malaria Prevention

Joob, B., & Wiwanitkit, V. (2022) · Journal of Datta Meghe Institute of Medical Sciences University · doi:10.4103/jdmimsu.jdmimsu_88_21

Comparison of Efficacy of Oral Azithromycin Versus Oral Chloroquine in the Treatment of Cutaneous Leishmaniasis

Bhutto, M., & Khan, M. R. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i4.834

Antimalarial compounds exhibit variant- and cell-type-specific activity against SARS-CoV-2 isolated in Panama

Quijada, M. R., Castillo, M., Díaz, Y., Pittí, Y., Franco, D., Guardia, C. D. L., Campos, D., Cornejo, E., Núñez, M., Mendoza, L., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1537053

Analytical approaches applied to antimalarial drugs analysis: a critical review

Geraldo, P. A., de Souza, J. C. Q., Marques, R. C. C., Castro, L. D. A., Adriano, L. H. C., de Moura, P. P. R., Chellini, P. R., & de Oliveira, M. A. L. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.118481

Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19

Lei, Z., Wu, Z., Dong, S., Yang, D., Zhang, L., Ke, Z., Zou, C., & Chen, Z. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107672 · Cited by 116 · see citing works

Antimalarials as Antivirals for COVID-19: Believe it or Not!

Saha, B. K., Bonnier, A., & Chong, W. H. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.08.019 · Cited by 22 · see citing works

Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective

Elhwuegi, A. S. (2020) · Libyan International Medical University Journal · doi:10.4103/liuj.liuj_11_20 · Cited by 1 · see citing works

Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection

Nicol, M. R., Joshi, A., Rizk, M. L., Sabato, P. E., Savić, R. M., WESCHE, D. L., Zheng, J., & Cook, J. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1993 · Cited by 35 · see citing works

Chloroquine and hydroxychloroquine in COVID 19

Pourgholami, M. H., & tavakoli, M. (2021)